Oncoceutics, Inc (Oncoceutics)

Oncology Corporate Profile

HQ Location

3624 Market Street
University City Science Center, Suite 5E
Philadelphia, PA 19104

Company Description

Oncoceutics, Inc. is a clinical-stage drug discovery and development company with a novel class of selective G protein-coupled receptor antagonists for oncology. The first lead compound to result from this program is ONC201, an orally active DRD2 small molecule antagonist that is well-tolerated and effective against advanced cancers. The company recently completed a successful Phase I study in solid tumors and has begun additional Phase I/II and Phase II clinical programs in both solid and hematological malignancies.

Website: http://oncoceutics.com/

This company does not have any commercial products

This company does not have any pipeline products

Pipeline image

Source


http://oncoceutics.com/

Recent News Headlines

There are no news items to display